Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination.
Published:
04/20/2026
Sirard, Jean-Claude et al - Vaccine/, vol. 80 128543. 4 Apr. 2026, doi:10.1016/j.vaccine.2026.128543
Flagellin, the key structural protein of bacterial flagella, is known to stimulate Toll-like receptor 5 (TLR5) signaling, making it an effective adjuvant for nasal, intramuscular, or subcutaneous routes of vaccination.
